• Avoid chasing CoreWeave (CRWV) around $60–$62 until its debt and financing risks become clearer; treat talk of an Nvidia backstop or Oracle rescue as unconfirmed speculation.
• Approach AI infrastructure stocks selectively: compare expected revenue with capital spending and debt, since strong computing demand does not guarantee durable returns.
• Don’t infer a clinical catalyst from Moderna (MRNA)’s rally or short 10x Genomics (TXG) or Ginkgo Bioworks (DNA) on the limited discussion alone; no supported targets or timelines were provided.

Anthropic (private)

• The speakers described Anthropic’s revenue growth as extraordinary, citing 50% quarter-over-quarter growth.
• Revenue was reported at $16.8 billion, below a $18 billion Street expectation. The transcript does not clarify whether those figures are quarterly revenue or an annualized measure.
• Anthropic reportedly projected a $110 billion revenue run rate by year-end. One speaker illustrated the valuation expectations around that figure: at 20× revenue, it would imply a $2.2 trillion market capitalization.
• The discussion cautioned that extremely rapid growth may eventually slow and that success can create its own challenges.

Takeaways

• The discussion highlights both the scale of Anthropic’s growth and the risk that investors may expect too much from it. Treat the $2.2 trillion figure as an illustrative valuation calculation, not a price target or recommendation.
• Investors evaluating private AI companies should distinguish between current revenue, projected run rate, and the valuation multiple being applied.

OpenAI (private)

• OpenAI was contrasted with Anthropic as a more deliberate grower, with the speaker saying it had prioritized a more measured approach to revenue growth.

Takeaways

• The comparison raises a strategic trade-off: rapid growth can build scale quickly, while a more measured pace may avoid some pressure associated with exceptionally high growth expectations. No investment recommendation or valuation was given.

CoreWeave (CRWV)

• CoreWeave was described as being “under siege,” with its stock falling from around $100 to about $60 and declining as much as 7% during the session before recovering toward $62.
• The speakers discussed concerns about the company’s debt and possible default risk. CoreWeave’s 2032 bonds were cited at roughly 80 cents on the dollar, though the speaker cautioned that the quoted bond prices might not be current.
• One speaker initially argued that Nvidia would need to make a $10 billion investment or other major commitment for CoreWeave’s rally to continue. Later, the discussion acknowledged Jensen Huang’s comments that a backstop was not necessary, while noting that investor concerns about CoreWeave’s debt could persist.
• An Oracle acquisition or rescue was raised as speculation, not as a confirmed plan. The speakers also said CoreWeave claimed it had no immediate troubles.

Takeaways

• CoreWeave was presented as a high-risk, high-volatility investment where debt, financing access, and customer or partner support matter alongside demand for AI computing.
• The discussion’s views shifted during the session; it did not establish that a bailout, acquisition, or recovery was assured. Monitor debt and bond pricing as well as the stock.

Nvidia (NVDA)

• Nvidia was mentioned as a potential source of support for CoreWeave, with one speaker proposing a $10 billion check as a way to bolster confidence. The conversation later said Nvidia did not need to backstop the company.
• Nvidia shares were reported down about 2.5% at one point, with the price action turning lower again during the session.
• The speakers noted that Nvidia’s relationship with CoreWeave could lead investors to see its public support as self-interested.

Takeaways

• Nvidia’s exposure to the broader AI-computing ecosystem may make its comments relevant to sentiment, but the transcript does not establish that Nvidia will provide financial support to CoreWeave.
• Do not treat the proposed $10 billion commitment as an announced deal.

Oracle (ORCL)

• Oracle shares were described as roughly flat, holding up amid a selloff in “neocloud” stocks.
• The speakers speculated that Oracle might make a move on CoreWeave or help rescue it. No deal or formal interest was confirmed.

Takeaways

• The Oracle–CoreWeave idea was speculation. Investors should look for a confirmed transaction or company statement before treating it as an investment catalyst.

Nebius (NBIS)

• Nebius was described as falling as much as 8%–10% during the session, later recovering somewhat but remaining down.
• It was discussed alongside CoreWeave as a high-beta AI-computing company exposed to sharp market swings.

Takeaways

• The session illustrated the volatility of AI infrastructure stocks. The transcript did not provide company-specific fundamentals or a recommendation for Nebius.

AMD (AMD)

• AMD shares were reported down as much as 7%, later recovering to a smaller loss.
• The speaker said customers use AMD processors, particularly CPUs, but that “nobody uses” AMD GPUs. This was the speaker’s characterization, not a detailed market-share analysis.

Takeaways

• The discussion distinguished AMD’s CPU business from its position in GPUs. Investors assessing AMD should consider those businesses separately rather than treating the company as a direct equivalent to Nvidia across all chip categories.

Memory and semiconductor stocks

• Micron (MU) was reported down about 4% during the session. The speakers also discussed concern that China could produce more memory and that a potential memory glut could weigh on the sector.
• Intel (INTC) was reported down as much as 5%, with a brief recovery followed by renewed weakness.
• ASML (ASML) was down about 2% and described as holding up relatively well.
• Broadcom (AVGO) was down about 3%.
• Marvell (MRVL) was down about 6%.
• Lumentum (LITE) was down about 8%.
• Kioxia was described as sharply lower. The transcript gives a Japanese market quote, but the exact price details are unclear.
• The speakers discussed a possible memory glut even as they described a broader shortage of computing capacity.

Takeaways

• The discussion points to competing forces in the semiconductor cycle: demand for AI computing versus concern that memory supply could expand too quickly.
• The transcript did not provide company-specific forecasts or recommendations for these stocks.

Twist Bioscience (TWST)

• The speaker said Twist had grown steadily for years and noted that its share price had fallen from around $200 to about $140.
• Despite calling the stock expensive at higher levels, the speaker said Twist might not be the best short candidate and emphasized how difficult shorting can be.

Takeaways

• The discussion warns against assuming that a stock is an attractive short simply because it has fallen or appears expensive. Short positions can be difficult to time and carry substantial risk.

10x Genomics (TXG) and Ginkgo Bioworks (DNA)

• Both names were mentioned as possible short candidates. The speaker was particularly negative on Ginkgo, calling it a poor-quality company.
• No price targets, time horizon, or detailed short thesis were provided.

Takeaways

• These were expressed as the speaker’s short ideas, not as fully supported recommendations. A short thesis requires company-specific analysis, and short positions can lose money if prices rise.

Apple (AAPL)

• Apple was described as slightly higher during a session when many technology stocks were lower.
• The transcript also includes a discussion of bids and a stated Apple position, but the order and holding details are garbled and should not be treated as reliable.

Takeaways

• Apple’s relative resilience was a brief market observation, not a stated investment recommendation.

Salesforce (CRM) and Palantir (PLTR)

• Salesforce was reported up about 2%, while Palantir was down about 3%.
• The speaker suggested software might be “back,” but did not provide a broader thesis or outlook for either company.

Takeaways

• The price action suggested a possible rotation toward software, but the transcript does not establish a durable trend.

SpaceX (private)

• SpaceX was reported down about 5% and described by the speaker as a “neocloud” because of its exposure to computing infrastructure.
• No valuation, investment terms, or direct investment recommendation was discussed.

Takeaways

• The comment links SpaceX to the AI infrastructure theme, but the transcript provides no basis for assessing its valuation or investability.

Quantum-computing stocks: D-Wave (QBTS), Rigetti (RGTI), and IonQ (IONQ)

• D-Wave was reported down about 3%, Rigetti about 4%, and IonQ about 3%.
• The stocks were mentioned as part of the broader market selloff. No company-specific outlook or recommendations were given.

Takeaways

• The transcript offers no distinct investment thesis for these companies beyond noting their price declines and exposure to a volatile theme.

Moderna (MRNA)

• Moderna was described as rallying strongly, with a quoted price of $230.
• The speaker called the strength impressive but said it was difficult to know whether the rally would continue.
• A potential Phase 3 disclosure was mentioned, but the speaker said they did not know what would happen. Another participant asked for the bull thesis, and no clear answer was provided.

Takeaways

• The discussion highlights uncertainty around the rally and upcoming clinical information. Investors should not infer a positive clinical outcome from the share-price move alone.

Biohaven (BHVN)

• The speakers mentioned upcoming obesity data and speculated that it might relate to a myostatin program. No result, date, or investment view was provided.

Takeaways

• The mention identifies a possible clinical catalyst, but the transcript does not confirm the program or provide enough detail to assess its significance.

Walmart (WMT)

• Walmart was described as benefiting from a rotation into the stock and was reported up about 4% during the session.

Takeaways

• This was a short-term market observation; no longer-term thesis or recommendation was given.

Broad market and AI-infrastructure theme

• The speakers discussed a selloff across AI-related technology and infrastructure stocks, despite describing a shortage of computing capacity.
• They questioned where AI companies’ large capital expenditures are going and whether weaker AI companies can sustain their spending if leading companies’ growth disappoints.
• Paul Tudor Jones was cited as warning that the market resembled 1999, before the 2000 bubble burst. One speaker disagreed, saying they did not see the same conditions.
• Another speaker suggested that panic and fear could be bullish and might create a buying opportunity, while acknowledging it could be early.

Takeaways

• The central theme is uncertainty over whether AI infrastructure spending will translate into durable revenue and returns. Investors should weigh growth and demand against capital intensity, debt, and the possibility of slower growth.
• The transcript presents conflicting market views—bubble risk versus a potential opportunity during panic—and does not provide a clear timing signal or broad market recommendation.